CI vs LAB
Cigna Corp (CI) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. LAB currently screens at market cap $317.1M.
Not investment advice. Open the CI and LAB stock pages for the full models.
Not investment advice.